Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 100 of 203 entries
View as:
Phase: N/A
Priority: Normal
Start: -
End: 04/30/02
Due: 04/30/03
Phase: N/A
Priority: Normal
Start: 09/30/06
End: 10/31/13
Due: 10/31/14
Phase: N/A
Priority: Normal
Start: 11/30/97
End: 03/31/02
Due: 03/31/03
Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer
Phase: N/A
Priority: Normal
Start: 01/31/00
End: 04/30/08
Due: 04/30/09
Phase: N/A
Priority: Normal
Start: 05/31/16
End: 05/31/26
Due: 05/31/27
Phase: N/A
Priority: Normal
Start: 11/30/03
End: 01/31/05
Due: 01/31/06
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/31/98
End: 02/28/03
Due: 02/28/04
Phase: N/A
Priority: Normal
Start: 11/27/17
End: 07/31/22
Due: 07/31/23
Phase: N/A
Priority: Normal
Start: 02/29/12
End: 06/30/17
Due: 06/30/18
Phase: N/A
Priority: Normal
Start: 01/14/16
End: 08/09/19
Due: 08/09/20
Phase: N/A
Priority: Normal
Start: 02/09/22
End: 08/22/22
Due: 08/22/23
Phase: N/A
Priority: Normal
Start: 12/11/15
End: 06/12/19
Due: 06/12/20
Phase: N/A
Priority: Normal
Start: 10/09/13
End: 07/06/18
Due: 07/06/19
Phase: N/A
Priority: Normal
Start: 07/31/08
End: 10/31/09
Due: 10/31/10
Phase: N/A
Priority: Normal
Start: 06/15/12
End: 11/18/20
Due: 11/18/21
Phase: N/A
Priority: Normal
Start: 07/31/08
End: 03/31/14
Due: 03/31/15
Phase: N/A
Priority: Normal
Start: 02/28/09
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 03/14/23
End: 09/23/27
Due: 09/23/28
Phase: N/A
Priority: Normal
Start: 06/24/22
End: 06/30/27
Due: 06/30/28
Phase: N/A
Priority: Normal
Start: 08/31/07
End: 06/23/17
Due: 06/23/18
Phase: N/A
Priority: Normal
Start: 08/14/15
End: 04/25/17
Due: 04/25/18
Phase: N/A
Priority: Normal
Start: 03/31/06
End: 06/30/10
Due: 06/30/11
Phase: N/A
Priority: Normal
Start: 09/22/20
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 05/27/18
End: 12/31/19
Due: 12/31/20